Heather Poad

[Sylwia Bujkiewicz @SBujkiewicz]

PhD opportunity with me at @UoL_Biostats, @Richard_D_Riley, Anne Thomas and Samantha Wilkinson at Roche. Model-driven and data-driven solutions for regulatory and HTA decision-making to address emerging challenges in drug development in cancer. Apply here: https://t.co/AxWEo7Y3QU

[Sylwia Bujkiewicz @SBujkiewicz]

Nice talk at #ISPOREurope by ⁦@WheatonLorna⁩ NIHR predoctoral fellow at @UoL_Biostats @NIHRresearch

[Heather Poad @HeatherPoad]

Lovely to watch @SBujkiewicz in action at the last breakout session of #ISPOREurope 2022: sharing of information in evidence synthesis to strengthen HTA decisions. @UoL_Biostats

[Sylwia Bujkiewicz @SBujkiewicz]

More ⁦⁦@NIHRresearch⁩ at #ISPOREurope by Jan Singh from his NIHR doctoral fellowship ⁦@UoL_Biostats⁩

[Sylwia Bujkiewicz @SBujkiewicz]

This is us! BayesHTA ⁦@UoL_Biostats⁩
Nice to be part of #ISPOREurope
⁦@HeatherPoad⁩ ⁦⁦⁦@WheatonLorna⁩ and Jan Singh

[Sylwia Bujkiewicz @SBujkiewicz]

@HeatherPoad MSR21: Exploration of the Impact of the Treatment Mechanism of Action on the Surrogate Relationship Between Progression Free Survival and Overall Survival in Metastatic Colorectal Cancer Monday Poster Session 1; 10:00-13:15

[Heather Poad @HeatherPoad]

@STEMinist_Coles @STEMinist_Coles not a paper directly on this but this paper has just been published by myself on similar themes https://t.co/NHsgWDJGbL

[Heather Poad @HeatherPoad]

Thanks @SBujkiewicz for sharing my paper, beat me to tweeting about it! This is my first, first author paper, and the first paper published from my PhD @Cancers_MDPI @UoL_Biostats

[Heather Poad @HeatherPoad]

Presenting my poster: Exploration of the impact of the treatment mechanism of action on the surrogate relationship between Progression free survival and overall survival in metastatic colorectal cancer, at #ISPOREurope today!

[Heather Poad @HeatherPoad]

@SBujkiewicz @michaelsweeting @WheatonLorna @UoL_Biostats @Impact_Aim_Mrc

[Sylwia Bujkiewicz @SBujkiewicz]

My team and I from @UoL_Biostats are presenting at #ISPOREurope
7 presentations on evidence synthesis: methods and applications – details to follow in the thread

[Heather Poad @HeatherPoad]

Thanks @SBujkiewicz for sharing my paper, beat me to tweeting about it! This is my first, first author paper, and the first paper published from my PhD @Cancers_MDPI @UoL_Biostats

[Sylwia Bujkiewicz @SBujkiewicz]

New paper - congratulations @HeatherPoad on the first paper from your PhD: The Validity of Surrogate Endpoints in Sub Groups of Metastatic Colorectal Cancer Patients Defined by Treatment Class and KRAS Status https://t.co/RlqbRAfCsX #mdpicancers via @Cancers_MDPI

[Heather Poad @HeatherPoad]

Attending #HTAi2021VirtualAM this week. Last day already! Proud to have my poster "Validity of Surrogate Endpoints in Subgroups of Patients with Advancd Colorectal Cancer Defined by the KRAS Biomarker Status" co-authors @SBujkiewicz @michaelsweeting up in the poster gallery.

[anon doctor @anonNHSdoctor]

Final year UK med student here. Going public with some experiences of a compulsory online exam. Summary: students threatened with disqualification from becoming doctors (in a pandemic) due to problems with online exams (incl. some being forced to urinate in their seats)

[Heather Poad @HeatherPoad]

I signed the petition for 100% responsibility in chocolate supply chains. MAKE SOME NOISE with me: https://t.co/oBuLTAiIDF

[Heather Poad @HeatherPoad]

@SamuelJTromans Glad your starting to feel better Sam!

[Jon Deeks FMedSci @deeksj]

This video from @educationgovuk uses the word "SAFE" six times. That is six lots of FALSE REASSURANCE. Negative results from a lateral flow test DO NOT make you safe. Please please please Government, get your heads round this FAST.

[Jamie Coleman, MD FACS @JJcolemanMD]

I’ve given half my life to medicine.
And medicine wouldn’t give my husband a chest x-ray.

Some kids stole a truck yesterday.
And they almost stole my husband’s life alongside it.

(1)

[Fight Bladder Cancer UK @BladderCancerUK]

Have you heard of #BladderCancer? It's time you did - it's the 5th most common cancer in Europe, and it affects all ages 🏵️ Share this post and help spread awareness 🏵️
Be #BladderCancerAware #5thmostcommon

[jim catto @JimCatto]

Radical Cystectomy Against Intravesical BCG for High-Risk High-Grade Nonmuscle Invasive Bladder Cancer: Results From the Randomized Controlled BRAVO-Feasibility Study https://t.co/BGPx4DemyU

[Heather Poad @HeatherPoad]

@SamuelJTromans Congratulations Sam!